We use cookies to personalise site content, social media features and to analyse our traffic. We also share information about your use of this site with our advertising and social media partners.
Description
FDA Finalizes Guidance Reviews for Cancer Clinical Trials
The US Food and Drug Administration (FDA) on Wednesday finalized guidance on an optional streamlined submission process for determining the risk of an investigational in vitro diagnostic (IVD) in a clinical trial where an investigational IVD is being co-developed with an oncology investigational drug.